Literature DB >> 12828700

Botulinum toxin: application into acupuncture points for migraine.

Bhertha Miyuki Tamura1, Bobby Chang.   

Abstract

BACKGROUND: : Botulinum toxin has been employed in orthopedics, physiatrics, gastroenterology, gynecology, neurology, pediatrics, general surgery, plastic surgery, and several other specialties. We have applied this drug to treat hyperhidrosis and wrinkles in dermatology; it offers also a secondary benefit: relief for headaches.
OBJECTIVE: : We have performed studies based on acupuncture principles in order to develop new botulinum toxin application sites for the treatment of migraine. These additional sites are helpful when patients expect results for both their illness and their wrinkles; whereas some patients will show improvement with the classic treatment for wrinkles, additional sites may be required.
METHODS: : Ten patients suffering from migraine, as diagnosed through the criteria proposed by the Headache Classification Committee of the International Headache Society, were selected. We used easily recognizable acupuncture sites for the injection of botulinum toxin.
RESULTS: : There was significant improvement in patients with acupuncture site-guided botulinum toxin injection. It showed to be a safe and effective therapy for migraine.
CONCLUSION: : There are alternative sites besides those used for the treatment of expression lines, which bring forth an improvement of migraine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12828700     DOI: 10.1046/j.1524-4725.2003.29183.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  3 in total

1.  Incorporating amino acids composition and functional domains for identifying bacterial toxin proteins.

Authors:  Min-Gang Su; Chien-Hsun Huang; Tzong-Yi Lee; Yu-Ju Chen; Hsin-Yi Wu
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

2.  Acupoint injection of onabotulinumtoxin A for migraines.

Authors:  Min Hou; Jun-Fan Xie; Xiang-Pan Kong; Yi Zhang; Yu-Feng Shao; Can Wang; Wen-Ting Ren; Guang-Fu Cui; Le Xin; Yi-Ping Hou
Journal:  Toxins (Basel)       Date:  2015-10-30       Impact factor: 4.546

3.  Botulinum toxin type a therapy in migraine: preclinical and clinical trials.

Authors:  Yu-Feng Shao; Yi Zhang; Peng Zhao; Wen-Jun Yan; Xiang-Pan Kong; Lin-Lan Fan; Yi-Ping Hou
Journal:  Iran Red Crescent Med J       Date:  2013-10-05       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.